Table 1.
Patient demographic data
| Characteristics | Prevalence |
|---|---|
| Ethnicity: white, n | 9 (75%) |
| Men, n | 10 (83.3%) |
| Age, yr | 53±12 |
| Dialysis vintage, mo | 56±6 |
| Fistula flow rate (Qa), ml/min | 1051±60 |
| BMI | 24.7 (21.7–30) |
| Dry weight, kg | 79 (56.5–92.8) |
| Primary renal diagnosis | |
| Unknown | 3 (25%) |
| Polycystic kidneys | 3 (25%) |
| Diabetic nephropathy | 2 (16.7%) |
| Other | 4 (33.3%)) |
| Diabetes mellitus | 4 (33.3%) |
| Current smoker | 2 (16.7%) |
| Residual renal function: creatinine clearance, ml/min | 1 (0–4) |
| NYHA status | |
| No heart failure | 11 (91.7%) |
| Heart failure NYHA Class 1 | 1 (8.3%) |
| Charlson Comorbidity Index, age adjusted | 4 (3–5) |
| Medications | |
| ACEi/ARB | 5 (41%) |
| β-Blockers | 4 (33.3%) |
| Two or more antihypertensive agents | 4 (33.3%) |
BMI, body mass index; NYHA, New York Heart Association; ACEi/ARB, angiotensin converting enzyme inhibitor, angiotensin receptor blocker.